Endometrial cancer (EC) is the third leading gynecological malignancy, and its treatment
remains challenging. B cell-specific Moloney murine leukemia virus integration site-1 (BMI1) …

Endometrial adenocarcinoma is one of the most common types of gynecological
malignancies and its incidence and mortality rates are increasing. Due to tumor recurrence …

With rising incidence rates, endometrial cancer is one of the most common gynecologic
malignancies in the United States. Although surgery provides significant survival benefit to …

Undoubtedly ovarian cancer is a vexing, incurable disease for patients with recurrent cancer
and therapeutic options are limited. Although the polycomb group gene, Bmi-1 that regulates …

BMI1 is involved in the occurrence and development of many types of cancer through a
variety of signaling pathways. BMI1, which is overexpressed in cancer, is often associated …

Introduction: B-cell-specific Moloney murine leukemia virus integration site 1 (Bmi-1) is a
member of polycomb group, which participates in axial patterning, hematopoiesis, cell cycle …

Background B-cell-specific Moloney murine leukemia virus integration site 1 (BMI1) might be
an appropriate biomarker in the management of epithelial ovarian cancer (EOC). However …

Background Bmi1, a polycomb group gene, is essential for self-renewal of stem cells and is
frequently upregulated in various cancer cells. We aimed to investigate the effect of Bmi1 …

Abstract Bmi-1 (B cell-specific Moloney murine leukemia virus integration site 1) is
upregulated in breast cancer and was involved in many malignant progressions of breast …

Breast cancer is a hormone-dependent malignancy and is the most prevalent cause of
cancer-related mortality among females. Radiation therapy and chemotherapy are common …